Compare Medtronic PLC (MDT) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Medtronic PLC trades at $82.6 (market cap $106.61B), while GraniteShares 2x Long NVDA Daily ETF trades at $31.09. The key difference: Medtronic PLC pays a 3.46% dividend while GraniteShares 2x Long NVDA Daily ETF pays none, and GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | NVDL | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $43.02 |
52-Week Low | $73.75 | $21.76 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $30.51 with a 0.76% daily gain. The technical outlook is bearish with moving averages signaling selling pressure, while oscillators remain neutral. Recent news highlights the fund's volatility, including a 12% single-day drop on June 5, 2026, and a 67% decline in early 2025, underscoring the risks of daily leverage reset mechanics.
The outlook for NVDL is heavily tied to NVIDIA's performance and AI sector momentum. While the ETF has delivered strong returns year-to-date (up 12.66% as of June 8, 2026), its leveraged structure amplifies both gains and losses. Key risks include NVIDIA's earnings volatility, broader semiconductor market swings, and the compounding effect of daily resets during downtrends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
